Primemd Inc
Primemd Inc., together with its subsidiaries, is engaged in the purchase and development of residential and commercial real estate properties in the United States. It also holds interests in oil and gas properties. The company was formerly known as Eagle Exploration Co. and changed its name to Primemd Inc. in June 2021. The company is based in Littleton, Colorado.
Primemd Inc (PRMD) - Net Assets
Latest net assets as of December 2021: $7.34 Million USD
Based on the latest financial reports, Primemd Inc (PRMD) has net assets worth $7.34 Million USD as of December 2021.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($15.32 Million) and total liabilities ($7.99 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $7.34 Million |
| % of Total Assets | 47.87% |
| Annual Growth Rate | 8.31% |
| 5-Year Change | 445.33% |
| 10-Year Change | N/A |
| Growth Volatility | 187.29 |
Primemd Inc - Net Assets Trend (2002–2021)
This chart illustrates how Primemd Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Primemd Inc (2002–2021)
The table below shows the annual net assets of Primemd Inc from 2002 to 2021.
| Year | Net Assets | Change |
|---|---|---|
| 2021-12-31 | $7.34 Million | +497.16% |
| 2007-12-31 | $1.23 Million | -10.18% |
| 2006-12-31 | $1.37 Million | +16.09% |
| 2005-12-31 | $1.18 Million | -12.42% |
| 2004-12-31 | $1.35 Million | -10.42% |
| 2003-12-31 | $1.50 Million | -6.64% |
| 2002-12-31 | $1.61 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Primemd Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 448930900.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2021)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $7.87 Million | 107.35% |
| Other Comprehensive Income | $7.87 Million | 107.35% |
| Total Equity | $7.34 Million | 100.00% |
Primemd Inc Competitors by Market Cap
The table below lists competitors of Primemd Inc ranked by their market capitalization.
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Primemd Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2007 to 2021, total equity changed from 1,228,362 to 7,335,284, a change of 6,106,922 (497.2%).
- Net income of 3,140,220 contributed positively to equity growth.
- Other comprehensive income increased equity by 7,881,548.
- Other factors decreased equity by 4,914,846.
Equity Change Factors (2007 to 2021)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $3.14 Million | +42.81% |
| Other Comprehensive Income | $7.88 Million | +107.45% |
| Other Changes | $-4.91 Million | -67.0% |
| Total Change | $- | 497.16% |
Book Value vs Market Value Analysis
This analysis compares Primemd Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.00x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-12-31 | $0.52 | $0.00 | x |
| 2003-12-31 | $0.49 | $0.00 | x |
| 2004-12-31 | $0.44 | $0.00 | x |
| 2005-12-31 | $0.38 | $0.00 | x |
| 2006-12-31 | $0.45 | $0.00 | x |
| 2007-12-31 | $0.40 | $0.00 | x |
| 2021-12-31 | $0.40 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Primemd Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 42.81%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 29.90%
- • Asset Turnover: 0.69x
- • Equity Multiplier: 2.09x
- Recent ROE (42.81%) is above the historical average (-5.50%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | -52.40% | -1447.11% | 0.04x | 1.01x | $-1.00 Million |
| 2003 | -9.84% | -255.07% | 0.04x | 1.01x | $-297.92K |
| 2004 | -11.85% | -407.34% | 0.03x | 1.01x | $-293.89K |
| 2005 | -13.20% | -295.44% | 0.04x | 1.01x | $-273.32K |
| 2006 | 14.24% | 396.19% | 0.04x | 1.00x | $57.96K |
| 2007 | -8.23% | -149.14% | 0.05x | 1.10x | $-223.96K |
| 2021 | 42.81% | 29.90% | 0.69x | 2.09x | $2.41 Million |
Industry Comparison
This section compares Primemd Inc's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $250,407,165
- Average return on equity (ROE) among peers: -38.80%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Primemd Inc (PRMD) | $7.34 Million | -52.40% | 1.09x | $2.96 |
| Addus HomeCare Corporation (ADUS) | $113.86 Million | 16.82% | 0.44x | $1.75 Billion |
| agilon health Inc (AGL) | $126.73 Million | -319.84% | 9.03x | $166.17 Million |
| Airsculpt Technologies Inc (AIRS) | $123.68 Million | 6.13% | 0.45x | $16.62 Million |
| Amedisys Inc (AMED) | $454.23 Million | -18.40% | 0.61x | $3.26 Billion |
| AMN Healthcare Services Inc (AMN) | $347.86 Million | 23.54% | 1.53x | $624.22 Million |
| American Shared Hospital Service (AMS) | $20.85 Million | 8.48% | 1.33x | $7.93 Million |
| American Oncology Network Inc. (AONC) | $226.04 Million | -0.05% | 0.10x | $112.23 Million |
| Ardent Health Partners, Inc. (ARDT) | $1.08 Billion | 4.65% | 3.71x | $225.22 Million |
| Arem Pacific Corporation (ARPC) | $-45.09K | 0.00% | 0.00x | $246.12K |
| Astrana Health Inc (ASTH) | $8.55 Million | -109.27% | 1.29x | $1.08 Billion |